Skip to main content
SpringerLink
Log in

Medication-Related Problems in Surgical Patients

  • Living reference work entry
  • First Online:
Principles and Practice of Geriatric Surgery

  • 75 Accesses

Abstract

Examples of age-related physiologic changes affecting drug pharmacokinetics

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. Dychtwald K (1999) Age power. How the 21st century will be ruled by the new old. Penguin Putnam, New York

    Google Scholar 

  2. Shock NW, Watkin DM, Yiengst MJ et al (1963) Age differences in the water content of the body as related to basal oxygen consumption in males. J Gerontol 18:1–8

    Article  CAS  PubMed  Google Scholar 

  3. Forbes GB, Reina JC (1970) Adult lean body mass declines with age: some longitudinal observations. Metabolism 19:653–663

    Article  CAS  PubMed  Google Scholar 

  4. Gilbaldi M (1992) Revisiting some factors contributing to variability. Ann Pharmacother 26(7–8):1002–1007

    Article  Google Scholar 

  5. Hammerlein A, Derendorf H, Lowenthal D (1998) Pharmacokinetic and pharmacodynamic changes in the elderly. Clin Pharmacokinet 35:49–64

    Article  CAS  PubMed  Google Scholar 

  6. Pickering G (2004) Frail elderly, nutritional status and drugs. Arch Gerontol Geriatr 38:174–180

    Article  CAS  PubMed  Google Scholar 

  7. Hanlon JT, Ruby CM, Guay D, Artz M (2002) Geriatrics. In: DiPiro JT, Talbert RL, Yee GC et al (eds) Pharmacotherapy: a pathophysiologic approach, 5th edn. McGraw-Hill, New York, pp 79–89

    Google Scholar 

  8. Turnheim K (1998) Drug dosage in the elderly: is it rational? Drugs Aging 13:357–359

    Article  CAS  PubMed  Google Scholar 

  9. Robertson DRC, Wood ND, Everest H et al (1989) The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa. Br J Clin Pharmacol 28:61–69

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Holdsworth MT, Forman WB, Killilea TA et al (1994) Transdermal fentanyl disposition in elderly subjects. Gerontology 40(1):32–33

    Article  CAS  PubMed  Google Scholar 

  11. Tozer TN, Winter ME (2005) Phenytoin. In: Burton ME, Shaw LM, Schentag JJ, Evans WE (eds) Applied pharmacokinetics: principles of therapeutic drug monitoring, 4th edn. Lippincott Williams & Wilkins, Baltimore, pp 463–488

    Google Scholar 

  12. Paxton JW, Briant RH (1984) Alpha one-acid glycoprotein concentrations and propranolol binding in elderly patients with acute illness. Br J Clin Pharmacol 1:806–810

    Article  Google Scholar 

  13. Castleden CM, George CF (1979) The effect of ageing on the hepatic clearance of propranolol. Br J Clin Pharmacol 7:49–54

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Tanaka E (1998) In vivo age-related changes in hepatic drug-oxidizing capacity in humans. J Clin Pharm Ther 23:247–255

    Article  CAS  PubMed  Google Scholar 

  15. Herlinger C, Klotz U (2001) Drug metabolism and drug interactions in the elderly. Best Pract Res Clin Gastroenterol 15:897–918

    Article  CAS  Google Scholar 

  16. Greenblatt DJ, Shader RI, Harmatz JS (1989) Implications of altered drug disposition in the elderly: studies of benzodiazepines. J Clin Pharmacol 29:866–872

    Article  CAS  PubMed  Google Scholar 

  17. Greenblatt DJ, Harmatz JS, Shader RI (1991) Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly: therapeutic considerations. Part I. Clin Pharmacokinet 21:165–177

    Article  CAS  PubMed  Google Scholar 

  18. Divoll M, Greenblatt DJ, Ochs HR, Shader RI (1983) Absolute bioavailability of oral and intramuscular diazepam: effects of age and sex. Anesth Analg 62:1–8

    Article  CAS  PubMed  Google Scholar 

  19. Herman RJ, Wilkinson GR (1996) Disposition of diazepam in young and elderly subjects after acute and chronic dosing. Br J Clin Pharmacol 42:147–155

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Rowe JW, Andres R, Tobin JD et al (1976) The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 31:155–163

    Article  CAS  PubMed  Google Scholar 

  21. Lindeman RD, Tobin J, Shock NW (1985) Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33:278–285

    Article  CAS  PubMed  Google Scholar 

  22. Bertino JS Jr (1993) Measured versus estimated creatinine clearance in patients with low serum creatinine values. Ann Pharmacother 27:1439–1442

    Article  PubMed  Google Scholar 

  23. Smythe M, Hoffman J, Kizy K et al (1994) Estimating creatinine clearance in elderly patients with low serum creatinine concentrations. Am J Hosp Pharm 51:198–204

    CAS  PubMed  Google Scholar 

  24. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41

    Article  CAS  PubMed  Google Scholar 

  25. Sanaka M, Takano K, Shimakura K et al (1996) Serum albumin for estimating creatinine clearance in elderly with muscle atrophy. Nephron 73:37–44

    Google Scholar 

  26. Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461–470

    Article  CAS  PubMed  Google Scholar 

  27. Lamb EJ, Webb MC, Simpson DE et al (2003) Estimation of glomerular filtration rate in older patients with chronic renal insufficiency: is the modification of diet in renal disease formula an improvement? J Am Geriatr Soc 51:1012–1017

    Article  PubMed  Google Scholar 

  28. Reichley RM, Ritchie DJ, Bailey TC (1995) Analysis of various creatinine clearance formulas in predicting gentamicin elimination in patients with low serum creatinine. Pharmacotherapy 15:625–630

    Article  CAS  PubMed  Google Scholar 

  29. Anonymous (2009) Risk of severe hypoglycemia with glyburide use in elderly patients with renal insufficiency. Veterans Health Administration (VHA) Pharmacy Benefits Management Services (PBM), Medical Advisory Panel (MAP), & Center for Medication Safety (VA Medsafe), July 29

    Google Scholar 

  30. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA (2001) Causes and consequences of comorbidity: a review. J Clin Epidemiol 54:661–674

    Article  CAS  PubMed  Google Scholar 

  31. Hoffman C, Rice D, Sung HY (1996) Persons with chronic conditions: their prevalence and costs. JAMA 276:1473–1479

    Article  CAS  PubMed  Google Scholar 

  32. Field TS, Gurwitz JH, Harrold LR et al (2004) Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 52:1349–1354

    Article  PubMed  Google Scholar 

  33. Safran DG, Neuman P, Schoen C et al (2002) Prescription drug coverage and seniors: how well are we closing the gap? Health Aff (suppl web exclusives):W253–W268. http://content.healthaffairs.org/cgi/reprint/hlthaff.w2.253v1.pdf. Accessed Feb 2009

  34. Mojtabai R, Olfson M (2003) Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff 22:220–228

    Article  Google Scholar 

  35. Qato DM, Alexander GC, Conti RM et al (2008) Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 300(24):2867–2878

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Boyd CM, Darer J, Boult C et al (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 294:716–724

    Article  CAS  PubMed  Google Scholar 

  37. Lorgunpai SJ, Grammas M, DSH L, McAvay G, Charpentier P, Tinetti ME (2014) Potential therapeutic competition in community-living older adults in the U.S.: use of medications that may adversely affect a coexisting condition. PLoS One 9(2):e89447. https://doi.org/10.1371/journal.pone.0089447

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Fick DM, Cooper JW, Wade WE et al (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163(22):2716–2724

    Article  PubMed  Google Scholar 

  39. Beyth RJ, Shorr RI (2002) Principles of drug therapy in older patients: rational drug prescribing. Clin Geriatr Med 18:577–592

    Article  PubMed  Google Scholar 

  40. Sloan RW (1992) Principles of drug therapy in geriatric patients. Am Fam Physician 45:2709–2718

    CAS  PubMed  Google Scholar 

  41. American Society of Consultant Pharmacists Top ten dangerous drug interactions in long-term care. Available at http://www.scoup.net/M3Project/topten. Accessed Feb 2009

  42. Tran, A, Jeffery SM, Nailor MD. (2016) Transition from Volume to Value: Medication Management after Hospital Discharge in the Elderly. Connecticut Medicine 80(8):495–501

    Google Scholar 

  43. Hanlon JT, Weinberger M, Samsa GP et al (1996) A randomized, controlled trial of a clinical pharmacist intervention to improve pre- scribing in elderly outpatients with polypharmacy. Am J Med 100:428–437

    Article  CAS  PubMed  Google Scholar 

  44. Gillespie U, Alasaad A, Henrohn D et al (2009) A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med 169:894–900

    Article  PubMed  Google Scholar 

  45. Richardson WC, Berwick DM, Bisgard JC et al (2000) The institute of medicine report on medical errors: misunderstanding can do harm. Quality of Health Care in America Committee. Med Gen Med 2(3):E42

    CAS  Google Scholar 

  46. Bates DW, Teich JM, Lee J et al (1999) The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 6(4):313–321

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Inouye SK, van Dyck CH, Alessi CA et al (1990) Clarifying confusion: the confusion assessment method: a new method for detection of delirium. Ann Intern Med 113:941–948

    Article  CAS  PubMed  Google Scholar 

  48. Inouye SK, Viscoli CM, Horwitz RI et al (1993) A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med 119:474–481

    Article  CAS  PubMed  Google Scholar 

  49. Inouye SK, Charpentier PA (1996) Precipitating factors for delirium in hospitalized elderly persons: predictive model and interrelation- ship with baseline vulnerability. JAMA 275:852–857

    Article  CAS  PubMed  Google Scholar 

  50. Marcantonio ER, Juarez G, Goldman L et al (1994) The relationship of postoperative delirium with psychoactive medications. JAMA 272:1518–1522

    Article  CAS  PubMed  Google Scholar 

  51. SK I, Bogardus ST, Charpentier PA et al (1999) Multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340:669–676

    Article  Google Scholar 

  52. Marcantonio ER, Flacker JM, Wright RJ, Resnick NM (2001) Reducing delirium after hip fracture. J Am Geriatr Soc 49:516–522

    Article  CAS  PubMed  Google Scholar 

  53. Jenike MA (1988) Psychoactive drugs in the elderly: antipsychotics and anxiolytics. Geriatrics 43(9):53–65

    CAS  PubMed  Google Scholar 

  54. Task Force on Late Neurological Effects of Antipsychotic Drugs (1980) Tardive dyskinesia: summary of a task force report of the American Psychiatric Association. Am J Psychiatry 137:1163–1172

    Article  Google Scholar 

  55. Smith JM, Baldessarini RJ (1980) Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch Gen Psychiatry 37:1368–1373

    Article  CAS  PubMed  Google Scholar 

  56. Schneider LS, Tariot PN, Dagerman KS et al (2006) Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. N Engl J Med 335:1525–1538

    Article  Google Scholar 

  57. Ray WS, Chung CP, Murray KT et al (2009) Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 360:225–235

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Ballard C, Hanney ML, Theodoulou M et al (2009) The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomized placebo-controlled trial. Lancet Neurol 8:151–157

    Article  CAS  PubMed  Google Scholar 

  59. Jenike MA (1988) Psychoactive drugs in the elderly: antidepressants. Geriatrics 43(11):43–57

    CAS  PubMed  Google Scholar 

  60. Yesavage JA, Brink TL, Rose TL et al (1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49

    Article  CAS  Google Scholar 

  61. Stimmel GL, Gutierrez MA (1995) Psychiatric disorders. In: Delafuente JC, Stewart RB (eds) Therapeutics in the elderly, 2nd edn. Harvey Whitney Books, Cincinnati, pp 324–343

    Google Scholar 

  62. Tourigny-Rivard MF (1997) Pharmacotherapy of affective disorders in old age. Can J Psychiatr 42(suppl 1):10S–18S

    Google Scholar 

  63. Alexopoulos GS, Katz IR, Reynolds CF, et al (2001) The expert consensus guideline series: pharmacotherapy of depressive disorders in older patients. Postgrad Med (Spec Rep):1–86

    Google Scholar 

  64. Perry PJ, Pfohl BM, Holstad SG (1987) The relationship between antidepressant response and tricyclic antidepressant plasma concentrations: a retrospective analysis of the literature using logistic regression analysis. Clin Pharmacokinet 13:381–392

    Article  CAS  PubMed  Google Scholar 

  65. Mukai Y, Tampi RR (2009) Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants. Clin Ther 31:945–961

    Article  CAS  PubMed  Google Scholar 

  66. Wallace AE, Kofoed LL, West AN (1995) Double-blind, placebo- controlled trial of methylphenidate in older, depressed, medically ill patients. Am J Psychiatry 152:929–931

    Article  CAS  PubMed  Google Scholar 

  67. Schneider LS (1996) Overview of generalized anxiety disorder in the elderly. J Clin Psychiatry 57(suppl 7):34–45

    PubMed  Google Scholar 

  68. Shuckit MA (1981) Current therapeutic options in the management of typical anxiety. J Clin Psychiatry 42(11, sect 2):15–26

    Google Scholar 

  69. Flamer HE (1995) Sleep problems. Med J Aust 162:603–607

    Article  CAS  PubMed  Google Scholar 

  70. Vaz Fragoso CA, Gill TM (2007) Sleep complaints in community- living older persons: a multifactorial geriatric syndrome. J Am Geriatr Soc 55:1853–1866

    Article  PubMed  PubMed Central  Google Scholar 

  71. Herr KA, Mobily PR (1991) Pain assessment in the elderly: clinical considerations. J Gerontol Nurs 17(4):12–19

    Article  CAS  PubMed  Google Scholar 

  72. Ferrell BA (1991) Pain management in elderly people. J Am Geriatr Soc 39:64–73

    Article  CAS  PubMed  Google Scholar 

  73. Ferrell BA (1995) Pain evaluation and management in the nursing home. Ann Intern Med 123:681–687

    Article  CAS  PubMed  Google Scholar 

  74. American Geriatrics Society Panel (2009) Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 57:1331–1346

    Article  Google Scholar 

  75. Barrett BJ (1996) Acetaminophen and adverse chronic renal out- comes: an appraisal of the epidemiologic evidence. Am J Kidney Dis 28(suppl 1):S14–S19

    Article  CAS  PubMed  Google Scholar 

  76. Morrison RS, Flanagan S, Fischberg D et al (2009) A novel inter- disciplinary analgesic program reduces pain and improves function in older patients after orthopedic surgery. J Am Geriatr Soc 57:1–10

    Article  PubMed  Google Scholar 

  77. Cantu TG, Korek JS (1991) Central nervous system reactions to histamine-2 receptor blockers. Ann Intern Med 114:1027–1034

    Article  CAS  PubMed  Google Scholar 

  78. Sanford JP, Gilbert DN, Moellering RC, Sande MA. (eds) (1997) Anti- infective drug–drug interactions. In: The Sanford guide to antimicrobial therapy, 27th edn. Antimicrobial Therapy, Vienna, pp 123–126

    Google Scholar 

  79. Smith DH, Perrin N, Feldstein A et al (2006) The impact of prescribing safety alerts for elderly patients in an electronic medical record. Arch Intern Med 116:1098–1104

    Article  Google Scholar 

  80. Bergman SJ, Speil C, Short M et al (2007) Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high risk populations. Infect Dis Clin N Am 21:821–846

    Article  Google Scholar 

  81. Gleckman RA (1995) Antibiotic concerns in the elderly. Infect Dis Clin N Am 9:575–590

    CAS  Google Scholar 

  82. Lesar TS, Lomaestro BM, Pohl H (1997) Medication-prescribing errors in a teaching hospital: a 9-year experience. Arch Intern Med 157:1569–1576

    Article  CAS  PubMed  Google Scholar 

  83. Gilbert DN, Bennett WM (1989) Use of antimicrobial agents in renal failure. Infect Dis Clin N Am 3:517–531

    CAS  Google Scholar 

  84. McCue JD (1992) Antimicrobial therapy. Clin Geriatr Med 8:925–945

    Article  CAS  PubMed  Google Scholar 

  85. Sanford JP, Gilbert DN, Moellering RC, Sande MA (eds) (1997) Dosage of antimicrobial drugs in adult patients with renal impairment. In: The Sanford guide to antimicrobial therapy, 27th edn. Antimicrobial Therapy, Vienna, pp 116–120

    Google Scholar 

  86. Mingeot-Leclercq MP, Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:100–112

    Article  Google Scholar 

  87. Posner JD (1982) Particular problems of antibiotic use in the elderly. Geriatrics 37(8):49–54

    CAS  PubMed  Google Scholar 

  88. Tablan OC, Reyes MP, Rintelmann WF et al (1984) Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in Pseudomonas endocarditis. J Infect Dis 149:257–263

    Article  CAS  PubMed  Google Scholar 

  89. Moore RD, Smith CR, Lietman PS (1984) Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J Infect Dis 149:23–30

    Article  CAS  PubMed  Google Scholar 

  90. Marra F, Partovi N, Jewesson P (1996) Aminoglycoside administration as a single daily dose. Drugs 52:344–370

    Article  CAS  PubMed  Google Scholar 

  91. Barza M, Ioannidis JPA, Cappelleri JC et al (1996) Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 312:338–345

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Hatala R, Dinh T, Cook DJ (1996) Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med 124:717–725

    Article  CAS  PubMed  Google Scholar 

  93. Raveh D, Kopyt M, Hite Y et al (2002) Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. Q J Med 95:291–297

    Article  CAS  Google Scholar 

  94. Van den Brande P, van Steenbergen W, Vervoort G et al (1995) Aging and hepatotoxicity of isoniazid and rifampin in pulmonary tuberculosis. Am J Respir Crit Care Med 152:1705–1708

    Article  PubMed  Google Scholar 

  95. Mandell LA, Bergeron MG, Ronald AR et al (1989) Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study. J Infect Dis 160:433–441

    Article  CAS  PubMed  Google Scholar 

  96. Barriere SL, Flaherty JF (1984) Third-generation cephalosporins: a critical evaluation. Clin Pharm 3:351–373

    CAS  PubMed  Google Scholar 

  97. Michielsen PP, Fierens H, Van Maercke YM (1992) Drug-induced gallbladder disease: incidence, etiology and management. Drug Saf 7:32–45

    Article  CAS  PubMed  Google Scholar 

  98. Brogden RN, Carmine A, Heel RC et al (1981) Cefoperazone: a review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy. Drugs 22:423–460

    Article  CAS  PubMed  Google Scholar 

  99. Rockoff SD, Blumenfrucht MJ, Irwin RJ et al (1992) Vitamin K supplementation during prophylactic use of cefoperazone in urologic surgery. Infection 20:146–148

    Article  CAS  PubMed  Google Scholar 

  100. Goss TF, Walawander CA, Grasela TH et al (1992) Prospective evaluation of risk factors for antibiotic-associated bleeding in critically ill patients. Pharmacotherapy 12:283–291

    CAS  PubMed  Google Scholar 

  101. Grasela TH, Walawander CA, Welage LS et al (1989) Prospective surveillance of antibiotic-associated coagulopathy in 970 patients. Pharmacotherapy 9:158–164

    Article  PubMed  Google Scholar 

  102. Schentag JJ, Welage LS, Williams JS et al (1988) Kinetics and action of N-methylthiotetrazole in volunteers and patients: population-based clinical comparisons of antibiotics with and without this moiety. Am J Surg 155(5A):40–44

    Article  CAS  PubMed  Google Scholar 

  103. MacGregor RR, Gibson GA, Bland JA (1986) Imipenem pharmacokinetics and body fluid concentrations in patients receiving high-dose treatment for serious infections. Antimicrob Agents Chemother 29:188–192

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Neu HC (1990) Aztreonam activity, pharmacology, and clinical uses. Am J Med 88(suppl 3C):2S–6S

    Article  CAS  PubMed  Google Scholar 

  105. Fillastre JP, Leroy A, Baudoin C et al (1985) Pharmacokinetics of aztreonam in patients with chronic renal failure. Clin Pharmacokinet 10:91–100

    Article  CAS  PubMed  Google Scholar 

  106. Davies BI, Maesen FPV (1989) Drug interactions with quinolones. Rev Infect Dis 11(suppl 5):S1083–S1090

    Article  CAS  PubMed  Google Scholar 

  107. Norrby SR, Ljungberg B (1989) Pharmacokinetics of fluorinated 4-quinolones in the aged. Rev Infect Dis 11(suppl 5):S1102–S1106

    Article  CAS  PubMed  Google Scholar 

  108. Stahlmann R, Lode H (2003) Fluoroquinolones in the elderly: safety considerations. Drugs Aging 20(4):289–302

    Article  CAS  PubMed  Google Scholar 

  109. van der Linden PD, Sturkenboom MC, Herings RM et al (2003) Increased risk of achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med 163:1801–1807

    Article  PubMed  Google Scholar 

  110. Holbrook AM, Pereira JA, Labiris R et al (2005) Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 165:1095–1106

    Article  CAS  PubMed  Google Scholar 

  111. Jones CB, Fugate SE (2002) Levofloxacin and warfarin interaction. Ann Pharmacother 36:1554–1557

    Article  PubMed  Google Scholar 

  112. Huang V, Gortney JS (2006) Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists. Pharmacotherapy 26:1784–1793

    Article  CAS  PubMed  Google Scholar 

  113. Clark DB, Andrus MR, Byrd DC (2006) Drug interactions between linezolid and selective serotonin reuptake inhibitors: case report involving sertraline and review of the literature. Pharmacotherapy 26:269–276

    Article  PubMed  Google Scholar 

  114. Taylor JJ, Wilson JW, Estes LL (2006) Linezolid and serotonergic drug interactions: a retrospective survey. Clin Infect Dis 43:180–187

    Article  CAS  PubMed  Google Scholar 

  115. Jobe BA, Grasley A, Deveney KE et al (1995) Clostridium difficile colitis: an increasing hospital acquired illness. Am J Surg 169:480–483

    Article  CAS  PubMed  Google Scholar 

  116. Mylonakis E, Ryan ET, Calderwood SB (2001) Clostridium difficile – associated diarrhea. A review. Arch Intern Med 161:523–533

    Article  Google Scholar 

  117. (2014) Drug Saf 37(4):201–211

    Google Scholar 

  118. Beers MH et al (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151(9):1825–1832

    Google Scholar 

  119. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 63:2227–2246

    Google Scholar 

  120. Gallagher P et al (2008) STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 46:72–83

    Article  CAS  PubMed  Google Scholar 

  121. Hanlon JT et al (2015) American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 63(12):e8–e18

    Google Scholar 

  122. Bedell SE et al (2000) Discrepancies in the Use of Medications: Their Extent and Predictors in an Outpatient Practice. Arch Intern Med 160(14):2129–2134. https://doi.org/10.1001/archinte.160.14.2129

  123. Scott IA et al (2015) Reducing Inappropriate Polypharmacy: The Process of Deprescribing. JAMA Intern Med 175(5):827–834. https://doi.org/10.1001/jamainternmed.2015.0324

  124. Reeve E et al (2013) Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging 30(10):793–807

    Article  PubMed  Google Scholar 

  125. Anderson K et al (2014) Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open 4(12):e006544

    Article  PubMed  PubMed Central  Google Scholar 

  126. Christensen M, Lundh A (2013) Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev 2:CD008986

    Google Scholar 

  127. Thomas R, Huntley AL, Mann M et al (2014) Pharmacist-led interventions to reduce unplanned admissions for older people: a systematic review and meta-analysis of randomised controlled trials. Age Ageing 43(2):174–187

    Article  PubMed  Google Scholar 

  128. Garfinkel et al (2010) Feasibility Study of a Systematic Approach for Discontinuation of Multiple Medications in Older Adults: Addressing Polypharmacy. Arch Intern Med 170(18):1648–1654. https://doi.org/10.1001/archinternmed.2010.355

  129. Tannenbaum C et al (2014) Reduction of Inappropriate Benzodiazepine Prescriptions Among Older Adults Through Direct Patient Education: The EMPOWER Cluster Randomized Trial. JAMA Intern Med 174(6):890–898. https://doi.org/10.1001/jamainternmed.2014.949

  130. Graves T et al (1997) Adverse Events After Discontinuing Medications in Elderly Outpatients. Arch Intern Med 157(19):2205–2210. https://doi.org/10.1001/archinte.1997.00440400055007

  131. Steinman MA, Hanlon JT (2010) Managing medications in clinically complex elders “There’s Got to Be a Happy Medium”. JAMA: J Am Med Assoc 304:1592–1601. https://doi.org/10.1001/jama.2010.1482

    Article  CAS  Google Scholar 

  132. Newman MF (2001) Longitudinal assessment of neurocognitive function after coronary artery bypass surgery. NEJM 344:395–402

    Google Scholar 

  133. Scazynski JS et al (2012) Cognitive trajectories after postoperative delirium. N Eng J Med 367(1):30–39

    Google Scholar 

  134. Pandharipande PP et al (2013) Long-term cognitive impairment after critical illness. N Engl J Med 369(14):1306–1316

    Google Scholar 

  135. Pandaripande P et al (2006) Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 104(1):21–26

    Google Scholar 

  136. Agostini JV et al (2001) Cognitive and Other Adverse Effects of Diphenhydramine Use in Hospitalized Older Patients. Arch Intern Med 161(17):2091–2097. https://doi.org/10.1001/archinte.161.17.2091

  137. Campbell NL et al (2009) The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging 4:225–233

    Google Scholar 

  138. Barr J et al (2013) Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 41:263–306

    Google Scholar 

  139. Khan BA et al (2015) Update on pharmacotherapy for prevention and treatment of post-operative delirium: a systematic evidence review. Curr Anesthesiol Rep 5:57–64

    Google Scholar 

  140. Neufeld KJ et al (2016) Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta-Analysis. J Am Geriatr Soc 64(4):705–714

    Google Scholar 

  141. Tomichek JE et al (2016) Antipsychotic prescribing patterns during and after critical illness: a prospective cohort study. Crit Care 20:378

    Google Scholar 

  142. Flurie RW et al (2015) Hospital delirium treatment: Continuation of antipsychotic therapy from the intensive care unit to discharge. Am J Health Syst Pharm 72(23 Suppl 3):S133–S139

    Google Scholar 

  143. Jasiak KD et al (2013) Evaluation of discontinuation of atypical antipsychotics prescribed for ICU delirium. J Pharm Pract 26:253–256

    Google Scholar 

  144. Tamam L, Ozpoyraz N (2002) Selective serotonin reuptake inhibitor discontinuation syndrome: a review. Adv Ther 19(1):17–26

    Article  CAS  PubMed  Google Scholar 

  145. Bratzler DW et al (2013) Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health-Syst Pharm 70:195–283

    Article  CAS  PubMed  Google Scholar 

  146. Akahane K et al (1994) Levofloxacin, an optical isomer of ofloxacin, has attenuated epileptogenic activity in mice and inhibitory potency in GABA receptor binding. Chemotherapy 40:412–417

    Article  CAS  PubMed  Google Scholar 

  147. Zhang LR et al (2003) Neurotoxicity and toxicokinetics of norfloxacin in conscious rats. Acta Pharmacol Sin 24:605–609

    CAS  PubMed  Google Scholar 

  148. Cohen SH et al (2010) Infect Control Hosp Epidemiol 31(5):431–455

    Article  PubMed  Google Scholar 

  149. Fox C, Smith T, Maidment I, Chan WY, Bua N, Myint PK, Boustani M, Kwok CS, Glover M, Koopmans I, Campbell N (2014) Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing 43(5):604–615

    Article  PubMed  Google Scholar 

  150. Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, Yu O, Crane PK, Larson EB (2015) Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Int Med 175(3):401–407

    Google Scholar 

  151. Campbell NL, Perkins AJ, Bradt P, Perk S, Wielage RC, Boustani MA, Ng DB (2016) Association of anticholinergic burden with cognitive impairment and healthcare utilization among a diverse ambulatory older adult population. Pharmacotherapy 36(11):1123–1131

    Google Scholar 

  152. Lau DT, Kasper JD, Potter DEB, Lyles A, Bennett RG (2005) Hospitalization and Death Associated With Potentially Inappropriate Medication Prescriptions Among Elderly Nursing Home Residents. Arch Intern Med. 165(1):68–74. https://doi.org/10.1001/archinte.165.1.68

  153. Stockl KM, Le L, Zhang S, Harada A (2010) Am J Manag Care. 16(1):e1–e10

    Google Scholar 

  154. Fick DM, Mion LC, Beers MH, L Waller J (2008) Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health. 31(1):42–51

    Google Scholar 

  155. Dowell D, Haegerich TM, Chou R (2016) CDC guideline for prescribing opioids for chronic pain – United States, 2016. MMWR Recomm Rep 65(RR-1):1–49. https://doi.org/10.15585/mmwr.rr6501e1. http://americanpainsociety.org/uploads/education/PAMI_Pain_Management_and_Dosing_Guide_April_2016.pdf

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT, USA

    Sean M. Jeffery

  2. Department of Pharmacy Practice, Purdue University College of Pharmacy, Indiana University Center for Aging Research, Indianapolis, IN, USA

    Noll Campbell

Authors
  1. Sean M. Jeffery
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Noll Campbell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sean M. Jeffery .

Editor information

Editors and Affiliations

  1. Surgical Service, Yale University School of Medicine VA Connecticut Health Care System, West Haven, CT, USA

    Ronnie A. Rosenthal

  2. SUNY Downstate School of Public Health, National Capital Region Johns Hopkins Medicine, Bethesda, MD, USA

    Michael E. Zenilman

  3. Center for Geriatric Surgery, Sinai Hospital of Baltimore, Baltimore, MD, USA

    Mark R. Katlic

Section Editor information

  1. Department of Surgery, David Geffen School of Medicine at the University of California, Los Angeles, CA, USA

    Marcia McGory Russell

  2. Ariadne Labs, Boston, MA, USA

    Zara Cooper

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Jeffery, S.M., Campbell, N. (2018). Medication-Related Problems in Surgical Patients. In: Rosenthal, R., Zenilman, M., Katlic, M. (eds) Principles and Practice of Geriatric Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-20317-1_12-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-20317-1_12-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-20317-1

  • Online ISBN: 978-3-319-20317-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation